Author

L. Staendker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Organism:zebrafish· 1

Frequent Co-Authors

J. Muench· 5 shared N. Preising· 4 shared A. Gilg· 3 shared F. Kirchhoff· 3 shared R. Gross· 3 shared C. Conzelmann· 2 shared J. A. Mueller· 2 shared K. M. Sparrer· 2 shared

Activity by Year

2020-2020 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

J. Muench

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Natural Cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling

M. Hayn, A. Bloetz, A. Rodriguez-Alfonso, S. Vidal, N. Preising, L. Staendker, S. Wiese, C. M. Stuerzel, M. Harms, R. Gross, C. Jung, M. Kiene, B. H. Hahn, T. Jacob, S. Poehlmann, , F. Kirchhoff

The paper identifies a Cystatin C fragment that inhibits GPR15-mediated HIV and SIV infection without affecting GPR15L signaling.

bioRxiv · Oct 26, 2020Microbiology

An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection

C. Conzelmann, A. Gilg, R. Gross, D. Schuetz, N. Preising, L. Staendker, B. Jahrsdoerfer, H. Schrezenmeier, K. M. Sparrer, T. Stamminger, S. Stenger, J. Muench, J. A. Mueller

This paper introduces an enzyme-based immunodetection assay to quantify SARS-CoV-2 infection by measuring viral spike protein expression in cell cultures.

Antiviral Research · Sep 1, 2020Peer-reviewedMicrobiology

An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

m. Harmse, M. M. Habib, S. Nemska, A. Nicolo, A. Gilg, N. Preising, P. Sokkar, S. Carmignani, M. Raasholm, G. Weidinger, G. Kizilsavas, M. Wagner, L. Staendker, A. M. Abadi, H. Jumaa, , J. Muench

The paper develops an optimized CXCR4 antagonist, JM#21, which effectively prevents atopic dermatitis and airway inflammation in mouse models.

bioRxiv · Aug 28, 2020Immunology

Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands

M. Harms, A. Gilg, L. Staendker, A. J. Beer, B. Mayer, V. Rasche, C. W. Gruber, J. Muench

bioRxiv · Jul 25, 2020Immunology

Alpha-1 antitrypsin inhibits SARS-CoV-2 infection

L. Wettstein, C. Conzelmann, J. A. Mueller, T. Weil, R. Gross, M. Hirschenberger, A. Seidel, S. Klute, c. Prelli-Bozzo, F. Zech, N. Preising, G. Fois, R. Lochbaum, P. Knaff, V. Mailaender, , J. Muench

The paper identifies 1-antitrypsin as a specific inhibitor of SARS-CoV-2, showing it blocks viral infection of human airway epithelium at physiological concentrations.

bioRxiv · Jul 2, 2020 · PreprintMicrobiology